Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

MLA

Malla, Sudhir B., et al. “Pathway Level Subtyping Identifies a Slow-Cycling Biological Phenotype Associated with Poor Clinical Outcomes in Colorectal Cancer.” Nature Genetics, vol. 56, no. 3, Mar. 2024, pp. 458–72. EBSCOhost, https://doi.org/10.1038/s41588-024-01654-5.

APA

Malla, S. B., Byrne, R. M., Lafarge, M. W., Corry, S. M., Fisher, N. C., Tsantoulis, P. K., Mills, M. L., Ridgway, R. A., Lannagan, T. R. M., Najumudeen, A. K., Gilroy, K. L., Amirkhah, R., Maguire, S. L., Mulholland, E. J., Belnoue-Davis, H. L., Grassi, E., Viviani, M., Rogan, E., Redmond, K. L., … Dunne, P. D. (2024). Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer. Nature Genetics, 56(3), 458–472. https://doi.org/10.1038/s41588-024-01654-5

Chicago

Malla, Sudhir B, Ryan M Byrne, Maxime W Lafarge, Shania M Corry, Natalie C Fisher, Petros K Tsantoulis, Megan L Mills, et al. 2024. “Pathway Level Subtyping Identifies a Slow-Cycling Biological Phenotype Associated with Poor Clinical Outcomes in Colorectal Cancer.” Nature Genetics 56 (3): 458–72. doi:10.1038/s41588-024-01654-5.